EC

Details for Australian Trade Mark No. 1462506 (hide)

Owner Endocyte, Inc.

Convention US 29 April 2011 85308116

Service Refer to WIPO Address for Correspondence

Various Convention priority claimed: 29 April 2011, United States of America, No. 85308116 in respect of PHARMACEUTICAL PREPARATIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER; PHARMACEUTICAL PREPARATIONS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES; PHARMACEUTICAL

Filing Date 22 October 2011

Classes

Class 5 Pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical preparations for the diagnosis and treatment of diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Class 42 Scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Event Publications

15 December 2011 Application filed

15 December 2011 Application Accepted

29 March 2012 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1462507-CEDAR RIDGE

1462505-CRUISE411